Public reporting burden fors collection Of infoma on is estimated to average I hour perresponse. including the Wm for reviewing instruions, searching existing data sources, gaeg and truntaining the data needed, and comrpleting and reviewing this collection of Infoniution. Send comments regarding this burden estimate or any other aspect of this colteclikon of Widornuton, including Expression of Disabled-2 (Dab2) is frequently lost in breast and ovarian epithelial cancers. Immunohistochemical staining has shown that this loss is an early event in tumorigenicity, since Dab2 is found absent in premalignant and otherwise morphologically normal tissue adjacent to malignant tissue. Retinoic acid (RA) treatment of F9 embryonic carcinoma cells induces Dab2 expression in both a time-and concentration-dependent manner, suggesting that Dab2 may be integral to retinoid acid signal transduction in differentiation and development. The purpose of the studies undertaken by the proposed research was to test the hypothesis that RA regulates Dab2 expression in breast epithelial cells, thereby inducing a negative growth regulator. Whether Dab2 expression and activation is one mechanism by which retinoids affect proliferation of mammary tumor cells, and the potential of retinoids as chemopreventive agents of mammary cancer, was to be explored. The studies had two'basic aims: 1) to determine the effect of retinoic acid on Dab2 expression in RA-sensitive breast cancer cell lines (MCF-7, T47D, SK-Br-3) compared to RA-resistant breast cancer cell lines (MDA-MB-231, MDA-MB-468); and 2) to determine the role of Dab2 in retinoic acid-sensitive growth control.
INTRODUCTION:
Expression of Disabled-2 (Dab2) is frequently lost in breast and ovarian epithelial cancers. Immunohistochemical staining has shown that this loss is an early event in tumorigenicity, since Dab2 is found absent in premalignant and otherwise morphologically normal tissue adjacent to malignant tissue. Retinoic acid (RA) treatment of F9 embryonic carcinoma cells induces Dab2 expression in both a time-and concentration-dependent manner, suggesting that Dab2 may be integral to retinoid acid signal transduction in differentiation and development. The purpose of the studies undertaken by the proposed research was to test the hypothesis that RA regulates Dab2 expression in breast epithelial cells, thereby inducing a negative growth regulator. Whether Dab2 expression and activation is one mechanism by which retinoids affect proliferation of mammary tumor cells, and the potential of retinoids as chemopreventive agents of mammary cancer, was to be explored. The studies had two'basic aims: 1) to determine the effect of retinoic acid on Dab2 expression in RA-sensitive breast cancer cell lines (MCF-7, T47D, SK-Br-3) compared to RA-resistant breast cancer cell lines (MDA-MB-231, MDA-MB-468); and 2) to determine the role of Dab2 in retinoic acid-sensitive growth control.
BODY:
Based on the original hypothesis, we evaluated the ability of retinoic acid to induce Dab2 in the breast carcinoma cell lines, MCF-7, T47D, and SK-Br-3. In no case did retinoic acid induce Dab2 expression in these cells, although retinoic acid did readily induce Dab2 expression in F9 cells, in which four days of treatment with 0.1 gM RA induced Dab2 to levels normally found in the Dab2-expressing immortalized mouse ovarian (MOV) cells. RA also did not alter the growth properties of any of these cells, indicating that an upstream regulator of the RA effect was deficient. The results also suggested that RA by itself may have limited ability to act as a chemopreventive agent in mammary carcinogenesis.
We spent some time trying to develop mammary carcinoma cell lines having inducible Dab2 expression. Mouse and human Dab2 cDNA were separately inserted into the pMT-CB6 vector under the control of the metallothionine promoter. The vectors were individually transfected into MCF-7, as well as F9 cells, using either lipofectamine or electroporation. Clones resistant to G418 were selected and treated with 20-100 gM zinc sulfate, and Dab2 expression was assayed by Western analysis. Despite repeated attempts and transfections, we have been unable to isolate a clone that shows inducible expression of Dab2. This may be due either to the negative growth influence of Dab2 or to some problem with the vector; both of these possibilities are currently being investigated.
Studies using the F9 embryonic carcinoma cell line, however, showed that Dab2 uncoupled MAPK phosphorylation from its downstream activation of c-Fos. The affected step is the activation/phosphorylation of Elk-1, the transcription factor that regulates c-Fos expression. We have some evidence that Dab2 exerts its effect by preventing the translocation of activated MAPK into the nucleus, where it phosphorylates Elk-1. These studies are ongoing. Disabled-2 (Dab2) is a putative tumor suppressor in v-Raf, v-Jun, and v-Fos. The cellular components of these onbreast and ovarian cancers. Its expression is lost in a cogenes function in the Ras/MAPK pathway. The pathway is majority of tumors, and homozygous deletions have also a key target for cell transformation in tumor development been identified in a small percentage of tumors. Dab2 in that about 50% of cancers harbor an activating mutation of expression is absent or very low in the majority of breast Ras (6, 8) . The cell regulatory system has developed an intriand ovarian cancer cel lines, including MCF-7 and SK-cate network for the fine regulation of the Ras/MAPK pathway Br-3 breast cancer cells. Transfection and expression of to counter cell transformation. For example, normal human Dab2 in MCF-7 and SK-Br-3 cells suppress tumorigenic-fibroblasts will undergo senescence or programmed cell death ity. The cells reach a much lower saturation density and when an activated Ras is introduced (9, 10) . Growth factorhave reduced ability to form colonies on agar plates. In stimulated Ras signals are also feedback regulated/inhibited examining the signal transduction pathway of Dab2-following growth factor binding by receptor degradation (11), transfected cells, we found that serum-stimulated c-Fos dissociation of Sos and Grb2 upon phosphorylation of Sos by expression was greatly suppressed; however, the effects expression was greatly ippressed; howeve, nthes efftst activated MAPK (12) (13) (14) (15) , by the enzymatic actions of Ras GAP,
In MCF-7 and SK-Br-m cells, although n-Fos expression and by the actions of phosphatases specific for the kinases in was suppressed, the ErklI2, JNK, and p 38 K-•g activities the pathway. Additionally, the surrounding environment of the were unchanged or even increased. Serum-stimulated cells, such as contact with the extracellular matrix, can modify c-Fos expression is dependent on MAPKiErk activity be-the effects of growth factors on the activation of Ras/MAPK cause the MEK inhibitor PD98059 suppresses Erk activ-pathway (16, 17). In breast and ovarian cancers, mutations of ity and c-Fos expression. Therefore, Dab2 appears to Ras are rare, and activating mutations of other components in uncouple MAPK activation and c-fos transcription, the Ras/MAPK pathway are also uncommon (18). It is believed Thus, we conclude that Dab2 re-expression suppresses that regulators in the fine-tuning of the Ras/MAPK pathway tumorigenicity by reducing c-Fos expression at a site are lost, resulting in aberrant activation of the pathway. downstream of the activation of MAPK family Idnases. The conservation of the Ras/MAPK pathway in yeast, CaeBecause Dab2 is frequently lost in cancer, the uncou-norhabditis elegans and.Drosophila has helped to delineate the pling of MAPK activation and e-Fos expression may be a components and regulation of the pathway. In mammalian favored target for inactivation in tumorigenicity.
cells, the growth factor binds to its tyrosine kinase receptor and stimulates its autophosphorylation on its tyrosine residues. The phosphotyrosine residues on the receptor act as a docking Mitogen-activated kinases (MAPK), 1 also known as extracel-site for assembling critical intracellular signaling molecules at lular signal-regulated kinases (Erk), are the key downstream the cell membrane to initiate a signal cascade (19, 20) . The targets of the Ras pathway (1) (2) (3) . The MAPK pathway is used adapter molecule Grb2 binds to the tyrosine receptor through in numerous signaling systems involved in cell growth, differ-Shc or directly to the phosphotyrosine residue, bringing assoentiation, and development (1) (2) (3) (4) (5) . The Ras/MAPK pathway has dated Sos to activate Ras on the plasma membranes. Ras is the potential for oncogenic transformation of cells (6, 7) , as activated upon conversion to the GTP bound form and initiates revealed by the discoveries of viral oncogenes such as v-Ras, the Raf-1/MEK/MAPK kinase cascade. An established target for MAPK is Elk-i, a transcription factor required for transac-* These studies were supported by Grants R01 CA79716 and R01 tivation of c-Fos (21-23). c-Fos was first identified as a cellular CA75389 (to X XC Xu) from NC, National Insitutes of Health, and funds counterpart of the viral oncogene capable of cell transformation from OCRF (New York, NY). The costs of publication of this article were (24), and its expression is the target of regulation in cell growth defrayed in part by the payment of page charges. This article must control (25) . c-fos is an immediate early gene whose transcriptherefore be hereby marked "advertisement" in accordance with 18 U.S.C. tion is activated by serum and growth factors, and its expresSection 1734 solely to indicate this fact.
I To whom correspondence should be addressed: Ovarian Cancer sion is a key switch in cellular regulation (24, 25) . c-Fos, toProgram, Fox Chase Cancer Center, Philadelphia, PA 19111. Tel.: 215-gether with c-Jun, form the AP-1 transcriptional complex 728-2188; Fax: 215-728-2741; E-mail: XXu@fccc.edu.
required for the transcription of many genes important for cell
SThe abbreviations used are: MAPK, mitogen-activated protein ki-growth, differentiation, and transformation (26, 27).
nase; Erk, extracellular-signal regulated kinase; GST, glutathione SWe now report that the expression of c-Fos is a target for the transferase; Dab2, Disabled-2; JNK, Jun N-terminal kinase; MEK, MAPK or Erk kinase; Sos, Son-of-sevenless; DOS, daughter of seven-regulatory function of Disabled-2 (Dab2), a candidate tumor less; KSR, kinase suppressor of Ras; GAP, GTP-activating protein; suppressor of breast and ovarian tumors (28-30). Dab2, a Grb2, growth factor receptor binding 2; PID, phosphotyrosine-interact-mammalian ortholog of the Drosophila Abl kinase-interacting ing domain; PTB, phosphotyrosine binding domain; FBS, fetal bovine serum; AbN kinase, Abelson kinase; DMEM, Dulbecco's modified Eagle's protein Disabled (31), was isolated as a mitogen responsive medium; MIT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium phosphoprotein (32). Dab2 was identified by differential disbromide.
playing to be a gene whose expression was absent in ovarian
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Tis paper is available on line at http:/w•Av.jbc.org 35-mm wells were transfected with human Dab2 eDNA expression Materials-Kinase inhibitors, PD98059 and SB202190, were pur-construct or pcDNA3 vector alone using LipofectAMlINE. Two days chased from Calbiochem (San Diego, CA). Tissue culture plastic wares following transfection, the cells wore transferred to 100-mm plates and were obtained from Fisher Scientific Inc. (Springfield, NJ). DMEM cultured in medium with 300 ng/ml Zeomycin. The medium was meee w haim entuic Vchanged every 2"days to remove floating dead cells, and Zeomycinmedium was purchased from Mediotech (Herndoea, VA); fetal bovine resistant colonies formed were harvested using cloning cylinders and serum (FBS) was obtained from Atlanta Biologicals (Atlanta, GA); plated on 24-well plates. The cell cultureswere expanded, and a fraction antibiotic-antimycotic (100x ) solution, LipofectAMINE, and serum-free was used for analysis for Dab2 expression bky Western blot. P-actin was Opti-MEM I medium were purchased from Life Technologies, Inc. determined on the same blot as a protein-loading control. (Grand Island, NY). The ECL Western blot detection kit was purchased from PIERCE (Rockfort, IL); Hybrisol I hybridization solution was from Intergen Inc. (Purchase, NY); positively charged nylon membranes low melting point agarose top layer in culture medium, plated on top of were from Roche Molecular Biochemicals; general chemicals and sol-a 0.6% agarose bed in DMEM containing 101Z FBS and complete supvents including Me.,SO, ethanol, isopropyl alcohol, and agarose were plements. The agarose plates were incubated at 37 IC for 3 weeks, with from Sigma or Fisher and were of reagent grade or higher.
Dab2 Suppresses c-Fos Expression in Breast Cancer Cells
addition of fresh medium every 3 days. Cell Culture-MCF-7 and SK-Br-3 human breast cancer cells were Cell Cycle Analysis by Flow Cytomet'-y-Cells on 100-mm plates were purchased from ATCC. The cells were cultured in DMEM with 10; FBS harvested with trypsin-EDTA solution and pelleted by centrifugation. supplemented with 1% non-essential amino acid mix and antibiotic-The cells were then fixed with 70-' ethanol, pelleted. and resuspended antimycotic solution.
in propidium iodine staining solution for 30 min at 4 *C. The stained Antibodies and Western Blot-Anti-Dab2 antibodies were character-cells were analyzed by flow cytometry. ized previously (30-32). Anti-p96 antibodies were purchased from Transduction Labs. (Lexington, KY); anti-c-Fos was from UpState Bio-RESULTS technology (Lake Placid, NY); anti-p-actin was from Sigma; anti-Erkli2
Establishment of Dab2 Expression in MCF-7 and SK-Br-3 and phospho-Erkl/2 were from Biolab and Cell Signaling Technology Breast Cancer Cells-We have previously found that Dab2 is Inc. (Beverly, MA); anti-Elk-1 and anti-phospho-Elk-1 were from Pro-expressed in breast and ovarian epithelial cells, but its expresmega and Santa Cruz Biotechnology (Santa Cruz, CA). Western blotting was performed accoeing to standard procedures, as described sion is lost in the majority (about 851e) of breast and ovarian previously (33). In some cases, after gaining experience with usage of a tumor cells tested (28, 29, 30) . Forced expression of Dab2 in single antibody, two or more antibodies were used in the same incuba-tumor cells reduces cell growth, induces cell death, and suption to'detect various molecular weight proteins simultaneously.
presses tumorigenicity in the nude mouse xenograft model (29, Cell Transfection-The full-length human DAB2 cDNA (GenBankT ' 34) . To further determine the biological consequence of Dab2 loss accession number AF188298) was inserted into the pcDNA/zeo eukary-for the tumor cells and to examine the signal transduction pathotic expression vector (Invitrogen, La Jolla. CA). Plasmid DNA was purified using the Qiagen Maxiprep column, and LipofectAMINE rea-way affected, we have transfected and established Dab2 expresgent was used for transfection. Briefly, 2 #g of Dab2 expression con-sion in MCF-7 and Sk-Br-3 breast tumor cells. Dab2 expression is stiuct or vector control plasmid DNA was mixed with 20 ;l of Lipo-absent in these two breast carcinoma cell lines (30). fectAMINE in I inl of Opti-MEM and was added to cells for 16 h. The Following transfection of the human Dab2 cDNA in the transfection mix was removed, and fresh DMEM containing 10% FBS pcDNA expression vector into MCF-7 breast cancer cells, 26 was added. After 12 h, selection medium (DMEM with 101 FBS and zeomycin-resistant clones were selected. Of these clones, only 300 ng/ml of Zeomycin) was added to the cells. Following a 10-12 day selection with change of medium every 2 days to removed dead cells, two clones were found to express Dab2 as detected by Western selected clones were isolated and collected by cloning rings, expanded blot, and a single clone (clone 8) still retained Dab2 expression by further culturing, and examined for Dab2 expression by Western upon expansion of the cells in culture (Fig. 1A) . In contrast, 22 blotting, of 64 Sk-Br-3 clones selected retained some expression of the Cell Growth Analysis-Cell growth was determined by counting un-transfected Dab2, and the three high expressing clones 49, 50, dera microscope and the MTT assay (Promega). For cell counting. cells and 57 were chosen for further analysis (Fig. 1B) . Three ran-(around 10r per plate) were plated in 35-mm tissue culture dish (6-well dish),and medium was changed daily. At the indicated times, cells were domly selected vector transfected clones of each cell line were harvested in 1 ml of trypsin-EDTA, collected by centrifugation and expanded for use as controls. resuspended in 100 14l of phosphate-buffered saline for counting. For
Transfection and Expression of Dab2 Inhibit Cell Growth the &MT assay. cells (around 10') were plated in 96-well plates, and and Transformation in MCF-7 and Sk-Br-3 Breast Cancer medium was changed daily. On the indicated day, the MTI dye was Cells-Upon establishment of the Dab2-expressing cells, we added and incubated with the cells for 2 h in the tissue culture incu-first characterized the growth properties of the cells. Transbator. The reaction was stopped by addition of cell solubilization solution. After 2 h at room temperature, the absorbance of the solution at fected MCF-7 cells (clone 8) were found to grow more slowly in 570 nm was measured with a microplate reader.
either low (0.1%) or high (10%) serum compared with vectorColony Formation on Agar Plates--Cells were embedded in a 0.31 transfected controls ( Fig. 2A) . A similar growth retardation (Fig. 2B) . The Dab2-and p3SaiA kinases following serum stimulation. MCF-7 cells transfected MCF-7 cells were found to have a reduced ability to transfected with vector or Dab2 (clone 8) were seeded on 35-mm plates. form colonies on agar plates; MCF-7-Dab2 clone 8 cells formed The cells were cultured without serum for 18 h and then stimulated fewer (about 20% of. control) and smaller colonies than vector-with serum for 0, 15, 30, 60, and 120 main. Cells were immediately washed twice with cold phosphate-buffered saline, lysed with SDS gel transfected clones (data not shown). All three clones of Dab2-loading buffer and boiled for 5 nin. The cell lysates were analyzed by transfected Sk-Br-3 cells also had a reduced ability to form Western blotting for MAPK activation with anti-phosphopeptide anticolonies on agar plates (not shown). All four selected I)ab2-bodies for Erkl/2, JnK and p38mAP. Expression of c-Fos was deterexpressing tumor cell clones were analyzed for cell cycle mined simultaneously on the same blot as MAPK activation. 3-Actin parameters using flow cytometry (Table I) . Compared with was used as a loading control. vector-transfected and non-transfected cells, both MCF-7 and Sk-Br-3 cells expressing Dab2 have about a 50% lower percent-was-also observed in transfection of-tumor cells with Dab2 age of cells in S phase and about 25% lower percentage of cells using an adenoviral vector in our previous investigation (34) . in G 2 /M phase, suggesting a prolonged G 1 phase. These results Thus, the suppression of c-Fos expression is not because of the are consistent with previous reports with different tumor cell particular properties of the selected cell clones but the result of lines on the negative cell growth regulatory properties and Dab2 expression. tumor suppressive activity of Dab2 (29, 35 (Fig. 3) . Similar effects of Dab2 expression in SK-Br-3 on Seram/EGF c-Fos expression and MAPK activation were found in Dab2-expressing clones (not shown). We also investigated and found no effect of Dab2 expression on Ras and Raf-1 activation (not shown). Thus, restoration of.Dab2 expression appears to dissociate MAPK activation and c-Fes expression in tumor cells.
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PD98059
The effect of Dab2 expression on other MAPK family kinases Raf4-including JNK and p 38 "'Px kinases was also investigated. Dab2 expression appears to have no significant and consistent
Dab2
effect on serum-stimulated JNK activity as detected by West-MA MAks) em blot with JNK-phosphopeptide specific antibodies (Fig. 3) . In either Dab2-expressing or vector-transfected MCF-7 and TCF-2, Elk-1 SK-Br-3 cells, serum stimulation did not notably activate L. 4 p38MAP1K as detected by anti-p38t1"'K phosphopeptide antibod-C-Fas ies (not shown), though in the same experiment, strong activation was observed in a positive control using anisomycin as a Fic. 6. Schematic model presentation of Dab2 regulation of stimulating agent.
c-Fos expression. Serum and growth factor activates Ras and MAP Effect of Kinase Inhibitors on c-Fos Expression-The effect of kinase, which is inhibited upon addition of the MEK inhibitor PD98059.
Phosphorylation of Elk-i by MAPK is required for serum-stimulated MAPK family kinase activation on c-Fos expression was fur-c-Fos transcription. The pathway is regulated by Dab2 by uncoupling ther explored in MCF-7 and Sk-Br-3 cells using kinase inhibi-MAPK activation and c-Fos expression. This regulatory mechanism is tors PD98059 and SB202190. In MCF-7 cells, the MEK inhib-often absent in tumor cells because of the loss of Dab2. itor PD98059 inhibited MAPK activation and c-Fos expression in a dose-dependent manner (Fig. 4A) , indicating PD98059-stimulated phosphorylation of Elk-i in MCF-7 cells and in inhibitable MAPK activity is necessary for serum to activate Sk-Br-3 cells (not shown). To explore the mechanism for the c-Fos expression. In contrast, the p 38 m^PK inhibitor SB202190, effects of Dab2 on MAPK and Elk-i, we examined the physical although it appears to reduce the basal state of MAPK activity, interaction between Erkl/2, Elk-I, and Dab2. In co-immunohad no inhibitory effect on serum-stimulated MAPK (Erk) ac-precipitation experiments, we found that Dab2 is not associtivation and c-Fos expression (Fig. 4B ). In comparison, inhibi-ated in any significant way with Erkl/2 or Elk-i, either the tion of c-Fos expression by MEK inhibitor PD98059 ( We found that Dab2 expression reduced the serum-found that serum-stimulated c-Fos expression is greatly sup-pressed. Expression of c-Fos is activated through the action of Mal cells, the Ras pathway is regulated by Dab2-mediated MAP kinase phosphorylation (21) (22) (23) . Surprisingly, the Erkl/2, uncoupling of MAPK activation and c-Fos expression. This JNX kinase, and P38gAPK activities were unchanged or even appears to be a favored target for inactivation during tumoriincreased upon serum stimulation in transfected Dab2-ex-genicity; tumor cells eliminate Dab2 and thus a regulatory site pressing cells compared with vector-transfected cells. Thus, we in the Ras pathway. Elk-I phosphorylation without affecting MAPK activation (36) .
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The affect of KSR on inhibition of Elk-1 phosphorylation is 13. Langlois, W. J., Sasaoka, T., Saliel, A. Retinoic acid induces cell differentiation and sup-tissue culture, retinoic acid induces cell differentiation and presses cell growth in a wide spectrum of cell lines, and suppresses cell growth in a wide spectrum of cell lines (4, 5) . down-regulation of activator protein-I activity by reti-The multipotent F9 embryonic carcinorja cells are often used noic acid contributes to these effects. In embryonic stem as a model to investigate the mechanism of retinoic acid in cell cell-like F9 teratocarcinoma cells, which are widely differentiation and cell growth control and the biochemical used to study retinoic acid actions on gene regulation basis of early embryonic development (8) (9) (10) (11) . Upon exposure to and early embryonic differentiation, retinoic acid treat-retinoic acid, F9 cells differentiate into primitive endodermment for 4 days resulted in suppression of cell growth like cells, accompanied by a reduction of cell growth (10, 11) . and differentiation into primitive and then visceral The primitive endoderm cells, which can be further differentiendoderm-like cells, accompanied by a suppression of ated into visceral and parietal endoderm cells, are organized serum-induced c-Fos expression. The MAPK (ERR) path-into a monolayer by a sheet of basement membrane in the early way was involved in mitogenic-signaling in F9 cells stim-embryos (12, 13) . The differentiated F9 cells express endoderm ulated with serum. Surprisingly, although c-Fos expres-markers such as GATA. 4 (14) , GATA-6 (15,16), and Dab2 '(17, sion was reduced, the MAPK activity was not decreased by retinoic acid treatment. We found that retinoic acid 18) and basement membrane components including collagen IV treatment inhibited the phosphorylation of Elk-l, a tar-and laminin (10, 19, 20) , thus resembling embryonic endoderm get of activated MAPK required for e-Fos transcription, cells in many biochemical properties. In F9 cells, the MAPKIMEK inhibitor PD)98059 supThe RasIMAPK pathway is involved in the induction of primpressed Elk-i phosphorylation and c-Fos expression, in.
itive endoderm differentiation of F9 cells (21), and suppression dicating that MAPK activity is required for Elk-i phos-of the pathway promotes embryonic stem cells for self-renewal phorylation/activation. Phosphoprotein phosphatase 2B (22). Up-regulation of AP-1 activity by retinoic acid contributes (calcineurin), the major phosphatase for activated to cell differentiation (23). c-Fos, a component of the AP-1 Elk-i, is not the target in the disassociation of MAPK complex, is expressed during the development of the early activation and c-Fos expression since its inhibition by embryos (24). An early study suggested that c-Fos expression cyclosporin A or activation by ionomycin had no signif-may be required for differentiation of F9 cells (25) . However, icant effects on serum-stimulated c-Fos expression and additional investigations have observed that c-Fos expression Elk-I phosphorylation. Thus, we conclude that retinoic is not increased during F9 cell differentiation (23,24,26) and is acid treatment to induce F9 cell differentiation uncou-not essential or sufficient for F9 cell differentiation (27-30). ples Bas/MAPK activation from c-Fos expression by reThe Ras/MAPK pathway is conserved in yeast, Caenorhabduction of Elk-1 phosphorylation through a mechanism ditis elegans, Drosophila, and mammals and functions in denot involving the activation of phosphoprotein phospha-velopment, cell regulation, growth, and differentiation (31). In tase 2B3. mammalian cells, the Ras/MAPK pathway mediates cell signaling of many growth factor receptor tyrosine kinases. Through adapters, GDP/GTP exchange to activate Ras, and a Betinoic acid is thought to be a master regulator in mamma-kinase cascade, the extraceflular signal causes the phosphoryllian development (1, 2) . A gradient of retinoic acid is found in ation/activation of cellular MAPK (ERK) (32-34). One estabthe developing embryo (1, 2), and retinoic acid plays a role in lished target for MAPK is Elk-i, a transcription factor required anterior-posterior determination, cell lineage induction, cell for transactivation of c-Fos (35-38). Subsequently, the AP-1 differentiation, organogenesis, and cell positioning (3) (4) (5) . In complex, of which c-Fos is a component, is assembled for gene adult tissues, retinoic acid also functions to maintain cell dif-transcription that mediates the biological response (38-40). ferentiation and is required for organ regeneration (6, 7) . In c-Fos was first identified as a cellular counterpart .of a viral oncogene capable of cell transformation (41) . An immediate-* This study was supported by NCI Grants R01 CA79716 and early gene whose transcription is activated by serum and CA75389 from the National Institutes of Health (to X.-X. X.) and p50 CA83638 (to T. C. H.) and by Ovarian Cancer Research Foundation (New York, NY). The costs of publication of this article were defrayed in 1 The abbreviations used are: Dab2, Disabled-2; MAPK, mitogenpart by the payment of page charges. This article must therefore be activated protein kinase; AP-1, activator protein-i; ERKM extracellular hereby marked "advertisement" in accordance with 18 U.S.C. Section signal-regulated kinase; FBS, fetal bovine serum; MTT, 3-(4,5-1734 solely to indicate this fact.
dimethylthiazol-2-yl)-2, EXPERIMENTAL PROCEDURES pma retinoic acid-On the final day, cell numbers were estimated using Materials-All-trans-retinoic acid and dibutyryl cAMP were pur-MTT assay. The absorbance at 570 nm is reported, representing relachased from Sigma. Kinase inhibitors PD98059 and SB202190, cyclo-tive cell numbers. Results are reported as the means t Si). of triplicate sporin A, and ionomycin were purchased from Calbiochem. Tissue cul-samples. Shown is a representative example of four independent ture supplies were obtained from Fisher. Dulbecco's modified Eagle's experiments. medium and fetal bovine serum (PBS) were purchased from Mediatech (Herndon, VA 
Suppression of c-Fos expression in F9 cells following
All-trans-retinoic acid was dissolved in Me 2 SO to a stock concentra-retinoic acid-induced primitive endoderm differentiation. F9 tion of 0.1 mm. Dibutyryl cAMP was dissolved in water to make a 50 mm cells were cultured for 4 days in Dulbecco's modified Eagle's medium stock. PD98059 and SB202190 were dissolved in Me 2 SO to make 50 and containing'10% FBS and 1 gm retinoic acid (RA) or Me 2 SO (DMSO) 6 mm stocks, respectively. These reagents were aliquoted, stored at solvent control. The cells were cultured on the last day without serum -20 °C, and kept from light exposure until used. For serum stimulation and then stimulated with 15% FBS, and cell lysates were used to experiments, the cells were first cultured for 18 h without serum in 1% determine c-Fos and P-actin levels (as a loading control) by Western bovine serum albumin or in low serum (0.5% FBS) and then were blotting. These results are representative of >10 independent stimulated with 15% FBS for various times.
experiments. M7TAssay-Cell growth and cell numbers were estimated using the MTT assay (Promega) according to the manufacturer's directions. neously in an incubation to detect various molecular mass proteins by Briefly, the cells were cultured in 96-well gelatin-coated plates (-101 Western lanaisc . cellsfwell) under the specified experimental conditions with the addi-Western blot analysis. tion of tested compounds. All experiments were performed in triplicate. RESULTS The medium was changed every 2 days. At the end of the specified incubation period, the VITT reagent (15 pl) was added to cells and MAPK Pathway Mediates Mitogenic Signaling in n9 Mouse incubated for 2-4 h. The reactions were terminated by the addition of Teratocarcinoma Cells-F9, an embryonic stem cell-like teratostop/solubilization solution (100 A1). Cell numbers were assessed spec-carcinoma cell line, can be differentiated into primitive and trophotometrically at 570 um by determining the conversion of tetra-visceral endoderm by treatment with retinoic acid (9-11) and is zolium salt to a colored formazan product. In our experience, the results often used in studies of early embryonic development and retfrom the MTT assay are consistent with cell number determined by inoic acid regulation (10) . Retinoic acid induced P9 cell differcounting.
Antibodies and Western Blot Analysis-Polyclonal anti-Dab2 anti-entiation, accompanied by cell growth suppression (Fig. 1 ), bodies were characterized as previously described (53) and were used which is mediated by retinoic acid receptor-P (10). Similar to for immunoprecipitation. Monoclonal anti-Dab2 (p96) ant%bodies were many somatic cells, proliferation of P9 cells is serum-dependpurchased from Transduction Laboratories (Lexington, KY). Anti-c-Fos ent. The MAPK pathway is involved in this mitogenic signaling antibodies were from Santa Cruz Biotechnology. Anti-actin antibodies since the MAPEIMEK inhibitor PD98059 inhibited serumwere from Sigma. Anti-ERK1/2 and anti-phospho-ERKI/2 antibodies were from Cell Signaling Technology. Immunoblotting was periormed stimulated cell growth (Pig. 1). Retinoic acid treatment also according to standard procedures as described previously (53) using a inhibited F9 cell growth, but to a smaller degree than PD98059. chemiluminescence system (Pierce). After confirmation of antibody se-In a representative example of four experiments, cell number lectivity, two or more antibodies were in some cases used simulta-following growth in the absence of serum was 16% of control At retinoic acid or in the presence of PD98059 was 38 or 26%, When the period of retinoic acid exposure was less than 1 day, respectively, of that of control cells cultured in 10% serum. retinoic acid had no effect on c-Fos expression in F9 cells (data One consequence of MAPK activation is the expression of not shown), and the inhibition of cell growth could be detected immediate-early genes such as c-fos (38, 42, 43). Retinoic acid only after retinoic acid treatment for 2 or more days, suggesting treatment for 4 days suppressed serum-stimulated c-Fos ex-that retinoic acid has no direct inhibitory effect on serumpression in F9 cells, as indicated by Western blotting (Fig. 2) , stimulated c-Fos transcription and that the inhibition is likely consistent with previous reports (23, 24, 26-30). In serum-the result of changes in the gene expression pattern during deprived F9 cells, serum stimulation resulted in elevated c-Fos endoderm differentiation. In contrast, suppression of c-Fos exexpression after 30 min and maximal expression by 90 min. In pression by PD98059 (see below) could be observed in 30 min, retinoic acid-treated cells, however, c-Fos expression was and inhibition of F9 cell proliferation could be detected during greatly suppressed (Fig. 2) . The decrease in c-Fos protein in the first day following the addition of the inhibitor. retinoic acid-treated cells correlates with a reduced level of •=P-Erk A and B). On the same blot, a suppression of c-Fos expression kd by retinoic acid treatment was observed (Fig. 3, A and B) . In 88 >10 experiments, we consistently observed a suppression of 65- Cells were then cultured in medium without serum containing 1% bovine serum albumin and I pgi retinoic acid or Me.SO solvent control. In both native and differentiated F9 cells, the MAPK isoform The inhibitors PD98059 (25 AM) and SB202190 (25 pie) were added to ERK2 is much more abundant than ERK1. This distribution cells for 30 min prior to stimulation with 15% FBS. A, cell lysates were differs in cells originating from adult animals such as the MOV prepared following 0 or 15 min of stimulation with FBS in SDS gel mouse ovarian surface epithelial cell line, in which both the loading buffer. The lysates were used to determine Elk-1 phosphoryla-" aotion and MAPK activation by immunoblotting using anti-phospho-Elk-1 ERKi and ERK2 isoforms of MAPK were, found in near equal (P-Elk-I) and anti-phospho-MAPK (P-Erk) antibodies sequentially. The amounts (Fig. 3D) .
same blot was then used to determine a-actin as a loading control. B, Inhibition of Elk-1 Phosphorylation following Retinoic Acid-cell lysates were prepared following 0 or 90 min of stimulation with induced Differentiation ofF9 Cells-Activated MAPK phospho-FBS, and c-Fos expression was determined by Western blotting. The same blot was then used to determine p-actin as a loading control. rylates the transcription factor Elk-1 at serine 383, and phos-Shown is a representative example of three separate experiments, with phorylated Elk-1 binds with the ternary complex to the c-fos similar results. promoter and activates transcription (36) . Upon serum stimulation of F9 cells, the phosphorylation of Elk-1 was found to be maximal at 30 min (Fig. 3, A and B) . We found that serum-serum-stimulated c-Fos expression in F9 cells. As a control, the stimulated Elk-1 phosphorylation was much reduced in reti-p 3 8 mAK inhibitor SB202190 did not inhibit MAPK activation, noic acid-induced F9 cells (Fig. 3, A and B) , despite a similar Elk-1 phosphorylation, or c-Fos expression (Fig.•4) , indicating MAPK activity in treated and untreated cells. Additionally, the that p 38 MAPK activation is not required for serum-stimulated protein level of total Elk-1 was unaltered following retinoic c-Fos expression in F9 cells. Thus, stimulation of MAPK activacid-induced differentiation (Fig. 3C) . In an immunocomplex of ity appears to be necessary and sufficient for Elk-1 phosphoanti-Elk-1 antibodies, the phosphorylation of Elk-1 at serine rylation and c-Fos expression in undifferentiated F9 cells. In 383 was much reduced following retinoic acid treatment, de-differentiated F9 cells, however, MAPK activation is not correspite a similar amount of total Elk-i protein found in Elk-i lated with Elk-I phosphorylation and c-Fos expression, indiimmunoprecipitates from either differentiated or undifferenti-cating that retinoic acid induces an uncoupling of MAPK activated cells (Fig. 3C) . Thus, the direct target of retinoic acid ity and Elk-1 phosphorylation/activation. treatment in the MAPK pathway and -suppression of c-Fos is
Retinoic Acid-induced Inhibition of c-Fos Expression Is Not the reduction of Elk-1 phosphorylation.
Due to an Increase in PP2B Activity-One precedent for uncouComparison of Suppression by Retinoic Acid-induced Differ-pling of MAPK activation and Elk-1 transcriptional activity is entiation and Inhibition by PD98095-Upon serum stimula-the enhancement of PP2B (calcineurin) activity by KSR (56). tion, a strong activation of MAPK (ERK1/2) was observed; PP2B is the major phosphatase for the dephosphorylation of however, no detectable JNK and p38MAP' activities were ob-phosphorylated/activated Elk-i, leading to down-regulation of served in retinoic acid-induced or undifferentiated control F9 its activity (57, 58). To determine if PP2B is responsible for the cells (data not shown). The MAPK/MEK inhibitor PD98059 reduced phosphorylation of Elk-1 and suppressed expression of inhibited both Elk-1 phosphorylation (Fig. 4A ) and c-Fos ex-c-Fos in retinoic acid-treated F9 cells, we examined the effect of pression (Fig. 4B) . However, unlike the effect of retinoic acid-ionomycin (activator of PP2B) in these cells. Cellular second induced differentiation, PD98095 also eliminated serum-stim-messenger calcium acting through calmodulin (59, 60) can aculated MAPK activation (Fig. 4A) . Inhibition by PD98095 tivate PP2B. In laboratory research, the calcium ionophore indicates that MAPK phosphorylation of Elk-1 is essential for ionomycin is commonly used to increase cytosolic calcium levels, thus to activate PP2B. The addition of ionomycin had no significant effect on c-Fos expression (Fig. 5A) , Elk-1 phospho-2 E. R. Smith, W.-P. Sun, J. D. Lambeth, and X-YX Xu, submitted for rylation (Fig. 5B) , or MAPK activation (Fig. 5C) ionomycin (1 MM) used, it appeared that the phospho-Elk-I DISCUSSION level was slightly decreased in Me2SO-treated control cells F9 cells are undifferentiated, with* characteristics resem- (Fig. 5B) ; however, no suppression of c-Fos expression could be bling those of stem cells in early embryos, and have been widely detected in the same experiment (Fig. SA) . Thus, the use of used to study early embryonic development and retinoic acid ionomycin to activate PP2B does not mimic the effect on c-Fos-regulation (9-11). Retinoic acid induction ofcell differentiation expression during retinoic acid-induced endoderm differentia-is usually accompanied by reduced cell proliferation, due to tion in F9 cells. suppression of cell cycle progression (62, 63) . The growth-supCyclosporin A is a specific inhibitor of PP2B (59, 61). If pressive activity of retinoic acid in F9 cells is retinoic acid retinoic acid treatment increases PP2B activity, leading to receptor-a-dependent (10). Although the mechanism for growth suppression of Elk-i phosphorylation and c-Fos expression, suppression by retinoic acid is not yet certain, several possibilcyclosporin A should cause an elevation or restoration of phos-ities have been investigated. One possibility is that retinoic phorylated Elk-1 levels and c-Fos expression in differentiated F9 cells. We found that inhibition of PP2B by cyclosporin A did acid suppresses cell growth by the induction of the transformnot enhance serum-stimulated c-Fos expression (Fig. 6A) , Elk-1 ing growth factor-.8 pathway (64). Many studies have also innot nhace eru-stmulaed -Fo exresion Fig 6A, Ek-I dicated that retinoic acid treatment inhibits AP-1 activity (52, phosphorylation (Fig. 6B) , or MAPK activation (Fig. 6, A and B) 6,6)te d that retinoic acid treatment reduced in either undifferentiated or differentiated F9 cells. In contrast, 65, 66). Here, we found that retinoic acid treatment reduced cyclosporin A appeared to slightly reduce c-Fos expression at serum-stimulated c-Fos expression. Surprisingly, retinoic acid high doses. Thus, the response of either undifferentiated or treatment had no effect on MAPK activation, thus uncoupling Sdifferentiated F9 cells to ionomycin and cyclosporin differs MAPK activation and c-Fos expression. The effect of retinoic from that of COS-7 and 293 cells, which are responsive regard-acid has been determined to be on the phosphorylation and ing c-Fos expression to these agents (56-58,67). Therefore, we activation of Elk-i, a transcription factor required for c-Fos conclude that the uncoupling of MAPK activation and c-Fos expression (Fig. 7) . expression by retinoic acid-induced F9 differentiation is at the A few studies have previously shown uncoupling of MAPK step of inhibition of Elk-1 phosphorylation (Fig. 7) . However, activation and Elk-1 phosphorylationlactivation (56, 67, 68). decreased Elk-i phosphorylation is not due to an increase in First, transfection ofthe KSR mammalian ortholog of Drosoph. PP2B activity following retinoic acid-induced differentiation in ila KSR can inhibit Elk-1 phosphorylation and activation with-F9 cells. Thus, through an unclear mechanism without the out affecting MAPK activity (56). The effect of KSR was shown participation of PP2B activation, MAPK activation and Elk-1 to be through the activation of PP2B (calcineurin), the major phosphorylation are disassociated in F9 cells following retinoic phosphatase for Elk-1 (57, 58). The mechanism for the activaacid-induced primitive endoderm differentiation, resulting in tion of PP2B by KSR has not been defined. A second example is suppression of c-Fos expression and correlating with cell the Grb2-binding adapter protein Gab2, the likely mammalian growth reduction.
ortholog of Drosophila DOS. Gab2 uncouples MAPK activity (Fig. 3A) (17). We have attempted transfection to establish ionomycin, and cyclosporin A on MAPK activation, Elk-I phosphorylaDab2 expression in F9 cells; however, none of the G418-resisttion, and c-Fos expression. Retinoic add-induced F9 cell differentiation results in the inhibition of c-Fos expression due to inhibition of Elk-1 ant clones were found to have significant Dab2 expression. phosphorylation. However, retinoic acid treatment does not inhibit Several additional genes including collagen IV are induced MAPK activation, unlike the action of PD98095. PP2B may dephospho-along with dab2 by GATA-6 during primitive endoderm differrylate Elk-i and suppresses c-Foes expression. Cyclosporin A inhibits entiation (17-19). Laminin is also induced directly by retinoic PP2B and may enhance Elk-1 activity and c-Fos expression, whereas ionomycin activates PP2B and may decrease Elk-1 phosphorylation and acid in F9 cells during retinoic acid-induced differentiation (10, suppress c-Fos expression. The lack of inhibition of c-Fos expression by 20). We speculate that expression of dab2 coordinately with ionomycin in undifferentiated F9 cells and the lack of a stimulating several additional genes achieves a balanced signal during F9 effect on c-Fos expression by cyclosporin A in retinoic acid-treated 9 cell differentiation; thus, expression of Dab2 alone (without cells suggest that PP2B is not involved in the regulation of Elk-1 phosphorylation and c-Fos expression in F9 cells during -endoderm additional working partners) is likely to be incompatible for cell differentiation.
maintenance and growth, which may account for the inability to isolate Dab2-transfected F9 cells.
16. Koutsourakis. M., Langeveld, A., Patient, R., Beddington, R., and Grosveld, F. F9 embryonic stem cell-like teratocarcinoma cells are orthologs of the Drosophila Disabled that was identified as one widely used to study early embryonic development and of the proteins genetically interacting with ANl kinase in fly cell differentiation. The cells can be induced by retinoic neuron development (1, 2) . The three spliced forms (p96, p93, acid to undergo endodermal differentiation. The reti-and p67) of murine Dab2 cDNA were first isolated as mitogennoic acid-induced differentiation accompanies cell responsive phosphoproteins functioning in the CSF-1 signal growth suppression, and thus, F9 cells are also often transduction pathway in macrophages (2) . DAB2 is thought to used as a model for analysis of retinoic acid biological be a tumor suppressor in ovarian cancer (3) (4) (5) (6) . Its expression is activity. We have recently shown that MAPK activation lost or greatly diminished in 85% of the breast and ovarian and c-Fos expression are uncoupled in F9 cells upon cancers analyzed (5), and forced re-expression of Dab2 supretinoic acid-induced endodermal differentiation. The presses cell growth and tumorigenicity (4, 6, 7) . Gene deletions expression of the candidate tumor suppressor Dis-have been found to account for the lbss of DAB2 expression in abled.2 is induced and correlates with cell growth sup-a pression in F9 cells. We were not able to establish stable a small percent of tumors. 
Disabled-2 expression by eDNA transfection in F9 cells
In vertebrates, retinoic acid plays a role in inducing cell without induction of spontaneous cell differentiation. lineage in early embryonic development, and defects in retinoic Transient transfection of Dab2 by adenoviral vector acid metabolism or exposure may result in abnormal developnevertheless suppresses Elk-1 phosphorylation, c-Fos ment (9, 10). The GATA transcription factors are believed to expression, and cell growth. In PA-1, another teratocar-serve as mediators of retinoic acid in the induction of the heart, cinoma cell line of human origin that has no or very low gut, and hematopoietic systems during development (9-13). levels of Disabled-2, retinoic acid fails to induce Dis-Retinoic acid induces gene expression and differentiation in abled-2, correlating with a lack of growth suppression, many cell types in culture and exhibits growth suppressive although PA-1 is responsive to retinoic acid in morpho-activity in a wide spectrum of tumor cells. Furthermore, retilogical change. Transfection and expression of Dis-noic acid has been used successfully to treat leukemia and has abled-2 in PA-1 cells mimic the effects of retinoic acid on been explored for use in treating other malignancies (14-16). growth suppression; the Disabled-2-expressing cells In in vitro studies of cultured tumor cells, retinoic acid supreach a much lower saturation density, and serum-stim-presses cyclin D induction and saturation cell density but does ulated c-Fos expression is greatly suppressed and disas-not affect log phase cell growth (17, 18). One of the several sociated from MAPK activation. Thus, Dab2is one of the possible mechanisms postulated for the effect ofretinoic acid on principal genes induced by retinoic acid involved in cell cell growth inhibition is the suppression of AP-1 activity (19, growth suppression, and expression of Dab2 alone is 20), which is the target of activation of the Ras/MEK (kinase for sufficient for uncoupling of MAPK activation and c-Fos MAPK or Erk)MAPK pathway by many mitogens. Retinoic expression. Resistance to retinoic acid regulation in acid also induces the transforming growth factor-p pathway, PA-I cells likely results from defects in retinoic acid another route for tumor/growth suppression in some systems up-regulation of Dab2 expression,.nte ot o uo/rwt upeso nsm ytm (21) . The action of retinoic acid is mediated through nuclear receptors that in turn modulate gene expression (9, 22) . AlDisabled-2 (DAB21 for the human. gene and Dab2 for the though some of the direct transcriptional targets of retinoic acid are known, such as the GATA factors (11) and laminin protein and gene in other species) is one of the two mammalian (23), the principal retinoic acid-controlled growth regulator(s) has yet to be identified, and the mechanisms for retinoic acid • This study was supported by NCI, National Institutes of Health regulation and resistance are as yet not fully understood. One Grants R01 CA79716 and R01 CA75389 and funds from the Ovarian of the remarkable changes in cell properties identified recently Cancer Research Foundation, New York (to Y.-X. X.) and by Depart-is that retinoic acid-induced differentiation of F9 cells accomment of Defense Grant DAMD17-01-1-0519 (to E. R. S.). The costs of panies the uncoupling of MAPK activation and c-Fos eiprespublication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" n (24), although the mediators of this retinoic acid-induced in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
alteration have not been identified. * To whom correspondence should be addressed: Ovarian Cancer
In addition, some tumor cells develop resistance to growth Program, Medical Science Division, Fox Chase Cancer Center, 7701 suppression by retinoic acid (25) . Loss of retinoic acid receptors Burholme Ave., Philadelphia, PA 19111. Tel.: 215-728-2188; Fax: 215-accounts for some cases, but other unidentified mechanisms 728-2741; E-mail: XXU@fcccedu. 1 The abbreviations used are: Dab2, Disabled-2; FBS, fetal bovine must exist (19, 25, 26) . In this study using F9 (retinoic acidserum; MAPK (Erk), mitogen-activated protein kinase (Erk, extracellular-signal regulated kinase); DMEM, Dulbecco's modified Eagle's medium; MOPS, 4-morpholinepropanesulfonic acid; MTT, 3-(4,5-dimeth-2 Z. Fazfli, Z. Sheng, W. Sun, C. Cohen, L. E. Mendez, I. R. Horowitz, ylthiazol-2-yl)-2,5-diphenyltetrazolium bromide.
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Dab2 Suppresses c-Fos Expression of Teratocarcinomas
sensitive) and PA-1 (retinoic acid-resistant) teratocarcinoma F9 cells were also transfected with metallothionein promoter-regucell lines, we identified the candidate tumor suppressor Dab2 lated mouse Dab2 construct in pMT-CB6+ vector, and green fluoresas a retinoic acid~inducible gene in F9 cells but not in PA-1 cent protein in pMT-CB6+ vector was used as a control. To induce expression, 0.1 mm1 ZnSO., was added to the medium for 24-72 h. cells. Dab2 was found to mediate the retinoic acid effect on cell Cell Cycle Analysi.s--Cell monolayers were released from plates with growth inhibition by suppressing c-Fos induction without al-0.25%4 trypsin, 0.11; EDTA and collected by centrifugation. The cells tering MAPK activation. Transfection/expression of Dab2 is were then fixed in 70r,' ethanol at 4 °C, pelleted. and re-suspended in 50 sufficient for cell growth suppression, suggesting that Dab2 is jsg/ml propidium iodide in phosphate-buffercd saline for 30 min at 4 *C. the major mediator of retinoic acid in cell growth suppression. The stained cells were analyzed by flow cytometry performed on a Moreover, the failure or inability to induce Dab2 may be a FACScan equipped with argon-ion laser and analyzed by Cell Quest mechanism for the resistance of tumor cells to retinoic acid in software (Bocton Dickinson).
Transient Transfcction of Dab2 Using Adcnoviral Approach-Replia growth suppression. cation-deficient adenovirus expressing Dab2 p96 or p67 spliced forms or PP-galactosidase were produced, purified, and titrated as described pro-EXPERIMENTAL PROCEDURES viously (6) . For transfection of F9 or PA-I cells, 100 multiplicity plaqueMaterials-Retinoic acid (all-trans., 9-cis-retinoic acid) and P-caro-forming units of adenovirus were added to the cells in medium with low tene were purchased from Sigma. Tissueculture supplies were obtained serum (1% FBS) for 4 h. The cells were then used for further experifrom Fisher. DMEM medium was purchased from Medintech(Herndon, mental manipulation. Under these conditions, more than 90, of the F9 VA); fetal bovine serum (FBS) was obtained from Atlanta Biologicals cells expressed the transfected cDNA, as estimated using adenovirus-(Atlanta, GA); TRIzol reagent, 1O0x antibiotic-antimycotic solution, expressing A-galactosidase. LipofectAMINE, and serum-free Opti-MEM I medium were purchased from Life Technologies, Inc.; the ECL Super-Signal West Dura extended RESULTS duration substrate immunodetection reagents were purchased from •2P]dCTP was from PerkinElmor Life Sciences. All tumor tissues and cultured carcinoma cells (5) . To evaluate other general chemicals and supplies including MeSO, ethanol, isopro-mechanisms for its loss, we examined potential factors that panol, and agarose were from Sigma or Fisher and were reagent grade might affect Dab2 expression. Dabi, the human ortholog that is or higher.
Cell Culture-F9 mouse teratocarcinoma and PA-1 human teratocar-mainly expressed in brain, can be induced by retinoic acid in cinoma cells were purchased from American Type Culture Collection the embryonic P19 carcinoma cell line (29) and by thyroid (ATCC). The PA-1 cells were cultured in DMEM supplemented with hormone (TS and T4) (30). Thus we investigated and found that 10Z FBS and lx antibiotic-antimycotic solution. F9 cells were cultured Dab2 can also be induced by.retinoic acid in the mouse embryon gelatin-coated tissue culture plates in DMEM containing 101h heat-onic teratocarcinoma F9 cell line, which is widely used as a inactivated FBS and <x antibiotic-antimycotic solution. The plates were coated with an autoclaved 0.111 gelatin solution overnight at 4 °C, model for studying effect-, of retinoie acid in gene transcription then washed three times with phosphate-buffered saline before use, and cell differentiation. Another recent report also confirmed Retinoids were added to cells from a 1 m.im stock solution in Me.SO. If it the ability of retinoic acid to induce Dab2 expression (31). is not specifically stated, all-trons-retinoic acid was used. Control culWe found that retinoic acid induces expression of both of the tures contained an equal volume of Me.,SO alone. Usually, retinoic acid two variably spliced forms of Dab2, p96-and p 67 (2) , in F9 cells. was added 24 h after plating of cells. Cell growth was determined by The effect is time (Fig. 1A) -and dose-dependent (Fig. 1B) . High either triplicate counting with a hemacytometer or measured using the MTI assay (Promega). The results of MTT assay agreed well with those levels of Dab2 protein were induced after treatment with retifrom cell counting.
noic acid for 4 days, and as little as 10-8 m retinoic acid Antibodies and Western Blot Analysis-Anti-Dab2 antibodies were stimulated Dab2 protein expression. Retinoic acid treatment characterized as previously described (2, 5, 6, 27) . Anti-Dah2 (p96) caused greater induction of the p67 form of Dab2, which differs monoclonal antibodies were purchased from Transduction Laboratories -from the expression pattern of Dab2 isoforms found in other (Lexington, KY); anti-c-Fos came from Santa Cruz Technology; anti-cells in which p96 is generally the major or only isoform (2, 5) . actin came from Sigma; anti-Erkl/2 and anti-phospho-Erkl/2 came from Cell Signaling Technology, Inc. (Beverly. MAI. Immunoblotting The induction of Dab2 by retinoic acid occurs at the transcripwas performed according to standard procedures, as described previ-tional level, because the Dab2 message RNA is induced in a ously (5, 6, 27) . After confirmation of antibody selectivity, in some cases similar magnitude as the protein (Fig. 1C) . Withdrawal of two or more antibodies were used simultaneously in an incubation to retinoic acid 4 days after induction did not reverse or decrease detect various molecular weight proteins.
Dab2 protein levels (Fig. 1D) , and even a month after retinoic Northern Blot Analysis-Total RNA was isolated from cell monolayers according to the TRIzol method (Life Technologies, Inc.). RNA was acid removal F9 cells continued to express Dab2 (not shown). separated on 1% agarose gel containing 717 formaldehyde and 20 mr.r These results correlate Dab2 expression with the.irreversible MOPS buffer, transferred to positive-charged nylon membranes using endoderm differentiation of F9 cells by retinoic acid treatment. 2x SSC ( x SSC = 0.15 .iNaCl and 0.015 m sodium citrate) buffer, and Among the retinoids tested, all-trans-retinoid acid is the most fixed by baking. DNA probes were labeled with [rt-''PldCTP using a potent in the induction of Dab2 (Fig. 1E) . 9-cis-Retinoic acid random prime labeling kit (Amersham Pharmacia Biotech). The hybrid-can induce Dab2 expression in F9 cells, but the required dosage ization and Northern blotting followed standard procedures as described previously (2, 5) .
is about 100 times more than that of all-trans-retinoic acid, and Cell Transfection-The full-length human DAB2 (28) or murine Dab2 N-(4-hydroxylphenyl)rotinamide (fenretinide or 4-HPR) and (2) cDNA was inserted into the pcDNA/zeo (Invitrogen, La Jolla, CA) or P-carotene (vitamin A) have no detectable activity (Fig. 1E) . pMT-CB6+ eukaryotic expres.sion vectors. Plasmid DNA was purified
In the PA-i teratocarcinoma cell line, however, retinoic acid using Qiagen Maxiprep columns. For transfection, 2 ;sg of Dab2 or treatment for 4 days did not induce Dab2 expression (Fig. 2A) . vector plasmid DNA were mixed with 20 id LipofectAMINE in 1 ml of PA-i cells were derived from a human ovarian germ cell tumor Opti-MEM and added to: PA-I or F9 cells for 16 h. F9 cells were transfected with mouse Dab2 eDNA, and PA-i cells were transfected (32) and are resistant to growth suppression by retinoic acid with human Dab2 eDNA. The transfection medium was removed, and (19, 33, 34) , in contrast to F9 cells. Longer duration of treatfresh DMEM containing 1017 FBS Was added. After 12 h, transfected ment with 1 Am retinoic acid for 2 weeks still failed to induce cells were cultured in DMEM containing 104 FBS and 300 ng/ml Dab2 expression in PA-i cells (data not shown). The lack of zeomycin for selection of pcDNA/zeo vector or 400 Waml G418 for Dab2 induction occurs at the transcriptional level, because no selection of pMT-CB6-vector. This selection medium was changed every 2 days. and after 10-12 days cloning rings were used to isolate changes in DAB2 mRNA were observed (Fig. 2B) Total RNA from ES2 ells was used as a p~ositive controL analysis, at least 6 clones appear to express the Dab2 p96
Retinoic Acid Induces Cell Growth Suppression in F9 but Not protein (Fig. 4A) . However, we have also observed that the in PA-1 Teratocarcinoma Cells and Induces Morphological ZnSO 4 -induced F9 cells undergo differentiation without retiChanges in Both Cell Lines-In parallel experiments, retinoic noic acid; the cells also express the p67 form of Dab2 (although acid inhibited the growth of F9 cells in a time (Fig. 3A) -and these were transfected with the p96 form ofDab2), and the cells dose-dependent manner (Fig. 3C) and also caused morphological also express GATA-4, GATA-6, collagen IV a2, and laminin, changes of the cells in culture (Fig. 3D) vector-transfected -cells - (Fig. 5B) . Additionally, these Dab2-expressing cells exhibited a reduced growth rate compared with vector-transfected controls (Fig. 50) . The ability to form a 0.colonies on agar plates was suppressed upon Dab2 expression (Fig: 5D) . Therefore, transfection experiments indicate that 0 expression of Dab2 suppresses cell proliferation and anchor- (Table I) . +RA +Beta-+Dab2 +Dab2
Thus, Dab2 inhibits'cell growth by suppressing G, phase proGal p96 p67 gression, which is similar to the effect of retinoic acid on the cell Adv Adv Adv cycle (17, 18, 26). MAPK activation and c-Fos expression (35). It is thought that retinoic acid reduces cell growth by suppressing AP-1 activity conclude that it is not possible to obtain stable Dab2-expressing of the Jun/Fos transcription complex (19,20) as does Dab2 (36) . F9 cells without also inducing spontaneous retinoic acid-inde-In F9 cells, we have found that retinoic acid-induced differenpendent differentiation. However, we are able to transiently tiation results in a -much weaker c-Fos induction by serum, express Dab2 by adenoviral approach (Fig. 4B ) without induc-although MAPK activation is not affected (Fig. 6A) . By adenoing differentiation of the F9 cells, as judged by the lack of virus transfection of Dab2, without induction of endoderm difexpression of the p67 spliced form of Dab2, GATA-4, and ferentiation, the Elk-1 phosphorylation and the c-Fos expres-GATA-6. Dab2 expression by the adenoviral approach sup-sion are inhibited (Fig. 6B) . Thus, expression of Dab2 alone is presses P9 cell growth (Fig. 40) , suggesting that retinoic acid-sufficient to alter the signaling in F9 cells. induced Dab2 expression is responsible for the cell growth Whereas c-Fos induction and MAPK activation in PA-1 cells inhibitory activity of retinoic acid in P9 cells.
were not altered by retinoic acid treatment (Fig. 6C) , we found There are undoubtedly many differences in the genetic back-that the expression of c-Fos was greatly reduced after serum ground and properties of mouse F9 and human PA-1 teratocar-stimulation in PA-i cells expressing Dab2 (Fig. 6C) . Remarkcinoma cells, although both cell lines have some properties of ably, the MAPK activation in these cells was not affected by Dab2 Suppresses c-Fos Expression of Teratocarcinomas .
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